Association of Reproductive Health Professionals
Association of Reproductive Health Professionals
Reproductive Health Topics Publications & Resources Professional Education Newsroom Membership Policy & Advocacy About Us
CME/CE Opportunities - By FORMAT
Send To A Friend Send To A Friend Bookmark this Page Share this page

Communicating Contraceptive Risk (Part 1/2)

On Demand Sessions:

Expiration Date Presenter Are you seeking credit?
October 31, 2021 Jacqui Quetal, FNP, MN Review webinar for CME/CE credit*

Review webinar without credit

*By clicking the webinar with credit link, you confirm that you have read the accreditation information on this page.

This is a one-hour internet-based activity. To receive continuing education credit, learners should 1) take the pre-test 2) review the webinar and 3) complete the post-test.

Learning Objectives

By the end of this activity, participants will be able to:

  • Define absolute risk, attributable risk, relative risk, and odds ratio.
  • Define risk as it relates to pregnancy and contraception.
  • Discuss perceptions of significant risk events and side effects
  • Identify effective communication strategies and tools within a larger counseling framework to better facilitate patient decision-making


Accreditation Information

Continuing Medical Education Credits: continuing Medical Education Credits: Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians, physician assistants, and certified nurse midwives. ARHP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits. Participants should only claim the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education Credits: Continuing Nursing Education Credits: Continuing medical education (CME) for physicians. ARHP designates 1.0 contact hours.

Sponsoring Information

This activity is sponsored by the Association of Reproductive Health Professionals.

Funding Information

This project and webinar is funded through an independent educational grant from Merck.


All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.

  • Toni Marengo-Barbick, MD (planning committee) is a consultant for Merck, Bayer Healthcare, & Teva Pharmaceuticals
  • Martha Simmons, MD, RHAP Fellow (planning committee) has nothing to disclose.
  • Jacqui Quetal, FNP, MN (planning committee and faculty) has nothing to disclose.
  • Diane Shannon, MD, MPH (medical writer) has nothing to disclose.
  • Doris Quintanilla (program manager) has nothing to disclose.
  • Dannie Dorrilus (program assistant) has nothing to disclose.